NCT03762343View on ClinicalTrials.gov

Ultrasound-guided Greater Occipital Nerve Block in Children Undergoing Posterior Fossa Craniotomy

PHASE3CompletedINTERVENTIONAL
Enrollment

40

Participants

Timeline

Start Date

January 1, 2019

Primary Completion Date

December 1, 2020

Study Completion Date

December 1, 2020

Conditions
Posterior Fossa Tumor
Interventions
DRUG

ultrasound guided Greater occipital nerve block

ultrasound guided Greater occipital nerve block with 2 ml of bupivacaine 0.5% (up to a maximum of 2 mg/kg) subcutaneous under ultrasound guidance in the greater occipital nerve region bilaterally.

DRUG

control group C

Patient in this group will receive the intraoperative standard of care(intraoperative intravenous fentanyl and paracetamol)

Trial Locations (1)

Unknown

Cairo University, Cairo

All Listed Sponsors
lead

Kasr El Aini Hospital

OTHER

NCT03762343 - Ultrasound-guided Greater Occipital Nerve Block in Children Undergoing Posterior Fossa Craniotomy | Biotech Hunter | Biotech Hunter